Parkinson Disease Psychosis
📧 Sign up to get email alerts when something new happens for Parkinson Disease Psychosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis [Phase 3]
Phase 3 study evaluating the safety and efficacy of pimavanserin for Parkinson's disease psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis [Phase 4]
Open-label Phase 4 study assessing pimavanserin on activities of daily living in Parkinson disease psychosis. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Bioequivalence Study of Pimavanserin 34 mg Capsule [Phase 1]
This update reports the completion of a Phase 1 bioequivalence study of pimavanserin 34 mg capsules for Parkinson disease psychosis.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis [Phase 2]
Phase 2 study evaluating SEP-363856 for Parkinson disease psychosis completed with results posted, detailing efficacy and safety/tolerabilit…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis [Phase 3]
Phase 3 trial evaluating safety and tolerability of pimavanserin (ACP-103) in Parkinson's disease psychosis has completed with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis [Phase 3]
Phase 3 study assessing safety and efficacy of pimavanserin in Parkinson's disease psychosis completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis [Phase 3]
Phase 3 trial results show safety and efficacy data for pimavanserin in Parkinson's disease psychosis; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis [Phase 3]
Phase 3 study evaluating pimavanserin for Parkinson's disease psychosis has completed. Results were posted in 2014.